Copyright
©The Author(s) 2024.
World J Psychiatry. Mar 19, 2024; 14(3): 380-387
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.380
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.380
Table 2 Serum marker levels
| Serum indicators | AD group (n = 60) | Control group (n = 60) | P value |
| CXCL12 (ng/mL) | 47.2 ± 8.5 | 32.8 ± 5.7 | < 0.001 |
| sCD22 (ng/mL) | 14.3 ± 2.1 | 18.9 ± 3.4 | < 0.01 |
| Lp-PLA2 (ng/mL) | 112.5 ± 20.6 | 89.7 ± 15.2 | < 0.05 |
- Citation: Liu ZL, Hua FF, Qu L, Yan N, Zhang HF. Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease. World J Psychiatry 2024; 14(3): 380-387
- URL: https://www.wjgnet.com/2220-3206/full/v14/i3/380.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i3.380